|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0016360,
umls-concept:C0023413,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0036525,
umls-concept:C0069717,
umls-concept:C0671970,
umls-concept:C0936012,
umls-concept:C1522484,
umls-concept:C1527249,
umls-concept:C1709595,
umls-concept:C2349200
|
|
pubmed:issue |
36
|
|
pubmed:dateCreated |
2008-12-19
|
|
pubmed:abstractText |
Six randomized phase II and III trials have investigated the role of oxaliplatin (OX) in combination with capecitabine (CAP) or infusional fluorouracil (FU) in metastatic colorectal cancer. This meta-analysis compared the efficacy of CAP/OX compared with infusional FU/OX.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:ArkenauHendrik-TobiasHT,
pubmed-author:ArnoldDirkD,
pubmed-author:CassidyJimJ,
pubmed-author:Diaz-RubioEduardoE,
pubmed-author:DouillardJean-YvesJY,
pubmed-author:GrotheyAxelA,
pubmed-author:HinkeAxelA,
pubmed-author:HochsterHowardH,
pubmed-author:MartoniAndreaA,
pubmed-author:PorschenRainerR,
pubmed-author:SchmiegelWolffW,
pubmed-author:SchmollHans-JoachimHJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5910-7
|
|
pubmed:dateRevised |
2009-12-11
|
|
pubmed:meshHeading |
pubmed-meshheading:19018087-Antimetabolites, Antineoplastic,
pubmed-meshheading:19018087-Antineoplastic Agents,
pubmed-meshheading:19018087-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19018087-Colorectal Neoplasms,
pubmed-meshheading:19018087-Deoxycytidine,
pubmed-meshheading:19018087-Fluorouracil,
pubmed-meshheading:19018087-Humans,
pubmed-meshheading:19018087-Infusions, Intravenous,
pubmed-meshheading:19018087-Leucovorin,
pubmed-meshheading:19018087-Neutropenia,
pubmed-meshheading:19018087-Organoplatinum Compounds,
pubmed-meshheading:19018087-Randomized Controlled Trials as Topic,
pubmed-meshheading:19018087-Survival Rate,
pubmed-meshheading:19018087-Thrombocytopenia,
pubmed-meshheading:19018087-Vitamin B Complex
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials.
|
|
pubmed:affiliation |
Drug Development Unit, Royal Marsden Hospital & Institute of Cancer Research, Downs Road, SM2 5PT Sutton, Surrey, United Kingdom. htarkenau@aol.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Meta-Analysis
|
